Medical Research Law & Policy Report® Index-Summary

E-HEALTH

– Lance Armstrong Foundation official, BNA Interview, 592
– Md. medical care database and data collection, 55
– Meaningful use of EHR

– – Changes sought by congressional leaders, 214
– – Final rules, 450
– – Patient safety, study planned, 623
– – Proposed CMS rule, 14; patient consent issues, 175
– – Redefinition, congressional letter, 143

– Outlook 2010, 5
– Safety monitoring

See SAFETY

– SHARP grants, 217
– White paper on E-records, HHS preparing, 141

EHR (ELECTRONIC HEALTH RECORDS)

See E-HEALTH

ENFORCEMENT POLICY

– Agenda from FDA, 787
– HIPAA privacy rule

See HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)

– Human subject protection

See HUMAN SUBJECT PROTECTION

– Outlook 2010, 5
– Recent administrative actions, chart, 30; 59; 90; 116; 151; 185; 222; 256; 289; 352; 387; 420; 461; 494; 529; 568; 591; 634; 665; 699; 764; 795
– Scrutiny of drugs and devices in 2010, BNA Insights, 122
– Trends in drug and device enforcement, 88

ENVIRONMENTAL PROTECTION

– BP spill and cleanup workers, 410
– Ft. Dietrick biocontainment labs environmental impact, 181
– Pesticide study subjects, EPA rule, 613
– Radioactive materials

See RADIOACTIVE MATERIAL

EPICOR

– Nutraceutical, use by Ankeny, Iowa, workers, 729

ERISA

– Bone cancer, “experimental treatment” coverage denial (S.D. Ohio), 73

EUROPEAN UNION (EU)

– Fee movement of researchers sought, 142
– Research needs, 24
– Soya, patent protection for genetic modification, 445
– Stem cell bank services, no VAT exemption, 371

EXPERIMENTAL TREATMENTS

– Bone cancer treatment, coverage denial (S.D. Ohio), 73
– Clinical trials

See CLINICAL TRIALS